ストックスクリーナーアプリを入手
51.77
0.21%
-0.11
アフターアワーズ：
51.77
Akero Therapeutics Inc (AKRO) 最新ニュース
Akero Therapeutics (NASDAQ:AKRO) Stock Price Down 3.3%Time to Sell? - MarketBeat
Don't Ignore The Insider Selling In Akero Therapeutics - simplywall.st
Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells 2,803 Shares of Stock - MarketBeat
Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) VP Sells 919 Shares of Stock - MarketBeat
Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) COO Sells 2,493 Shares of Stock - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $127,332.00 in Stock - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) CFO Sells $151,387.96 in Stock - MarketBeat
Rhumbline Advisers Purchases 5,001 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Millennium Management LLC Lowers Stock Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics (AKRO) Emerges as Attractive Acquisition Targ - GuruFocus
Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Bought by SG Americas Securities LLC - MarketBeat
Jefferies Names Akero Therapeutics, Scholar Rock As Biotech Companies With Takeover Potential, But Retail Isn’t Pleased By Stocktwits - Investing.com India
Jefferies Names Akero Therapeutics, Scholar Rock As Biotech Companies With Takeover Potential, But Retail Isn’t Pleased - MSN
Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $668,625.00 in Stock - MarketBeat
Investors Buy Large Volume of Call Options on Akero Therapeutics (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $1,376,000.00 in Stock - MarketBeat
Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) CEO Sells 37,837 Shares of Stock - MarketBeat
Akero Therapeutics Executives Sell Shares to Cover Tax Obligations - TradingView
(AKRO) Technical Data - news.stocktradersdaily.com
Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Transcript : Akero Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 02 - MarketScreener
Day 8 of Gains Streak for Akero Therapeutics Stock with 21% Return (vs. 97% YTD) [6/9/2025] - Trefis
MASH Market Size in the 7MM was ~USD 1.8 billion in 2023, is projected to grow at a CAGR of 24%, estimates DelveInsight - The Globe and Mail
Akero Therapeutics' Chief Scientific Officer Sells Shares - TradingView
Rumor Fuels Akero Therapeutics (AKRO) Stock Movement | AKRO Stoc - GuruFocus
Rumor Fuels Akero Therapeutics (AKRO) Stock Movement | AKRO Stock News - GuruFocus
Ameriprise Financial Inc. Purchases Shares of 15,172 Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) VP Patrick Lamy Sells 4,000 Shares - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Akero Therapeutics, Inc. (AKRO) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
2025-06-08 | Bronstein, Gewirtz & Grossman, LLC Encourages Akero Therapeutics, Inc. (AKRO) Shareholders to Inquire about Securities Investigation | NDAQ:AKRO | Press Release - Stockhouse
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World
Bank of America Corp DE Sells 93,294 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Day 7 of Gains Streak for Akero Therapeutics Stock with 20% Return (vs. 95% YTD) [6/6/2025] - Trefis
Ionis Pharmaceuticals (NASDAQ:IONS) versus Akero Therapeutics (NASDAQ:AKRO) Financial Contrast - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Therapeutics, Inc. (AKRO) And Encourages Shareholders to Connect - ACCESS Newswire
Ameriprise Financial Inc. Makes New Investment in Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World
Akero Therapeutics Elects New Directors at Annual Meeting - TipRanks
Two Sigma Advisers LP Acquires 27,200 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Bank of America Corp DE Has $1.84 Million Stock Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Akero Therapeutics, Inc. (AKRO) And Encourages Shareholders to Reach Out - ACCESS Newswire
0.68%
0.50%
大文字化:
|
ボリューム (24 時間):